Mutant FOXO1 controls an oncogenic network via enhancer accessibility
Mutant FOXO1 controls an oncogenic network via enhancer accessibility is a research paper published in Cell Genomics (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
βΊMethodology & internals
FAIR Checklist
Context only (not used in score)- Has DOI
- Open Access
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Authors (6)
National Institutes of Health
Grant: F31-HL156565
National Institutes of Health
Grant: T32-CA009582-33
National Institutes of Health
Grant: R01-CA164605
National Cancer Institute
Grant: R01-CA255446-01A1
National Cancer Institute
Grant: P30CA68485
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: P30DK58404
National Center for Advancing Translational Sciences
Grant: 2 UL1 TR000445-06
National Center for Research Resources
Grant: UL1 RR024975-01
NCI NIH HHS
Grant: R01 CA164605
NCATS NIH HHS
Grant: UL1 TR000445
NHLBI NIH HHS
Grant: F31 HL156565
NIDDK NIH HHS
Grant: P30 DK058404
NCI NIH HHS
Grant: P30 CA068485
NCRR NIH HHS
Grant: UL1 RR024975
NCI NIH HHS
Grant: R01 CA255446
NCI NIH HHS
Grant: T32 CA009582
National Institutes of Health
Grant: 1F31HL156565-01
Determining the role of WT and mutant FOXO1 in the transcriptional regulation of DLBCL
National Institutes of Health
Grant: 3P30CA068485-23S2
Cancer Center Support Grant
National Institutes of Health
Grant: 3UL1RR024975-03S4
The Vanderbilt Institute for Clinical and Translational Research (VICTR) UL1
National Institutes of Health
Grant: 5R01CA255446-03
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
National Institutes of Health
Grant: 1P30DK058404-01A1
CORE--MICROARRAY
National Institutes of Health
Grant: 5T32CA009582-34
Biochemical and Chemical Training for Cancer Research
National Institutes of Health
Grant: 4R01CA164605-05
Hdac3 as a therapeutic target in BCL6-dependent lymphoma
National Institutes of Health
Grant: 6UL1TR000445-11
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
Vanderbilt Cancer Center
V Foundation
T.J. Martell Foundation
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
FWCI
0.78
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords